The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users

Study identifier:D5040N00007

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users

Medical condition

Uncomplicated peptic ulcer

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

39000

Study type

Observational

Age

50 Years - 84 Years

Date

Study Start Date: 01 Nov 2012

Primary Completion Date: 01 May 2013

Study Completion Date: 01 May 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Madrid, Spain

Arms	Assigned Interventions
Patients with prescription for low dose ASA (75-300 mg/day)	-

"There is no result for the study"

Documents available

D5040N0007.pdf
Download
Trial Results Summaries
Available here

Contacts

Investigators

Principal Investigator

Luis A Garcia Rodriguez

CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )

The risk of uncomplicated peptic ulcer in a cohort of secondary prevention aspirin users

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Documents available

D5040N0007.pdf

Trial Results Summaries

Contacts

Investigators

Principal Investigator